On the 16th, Regarding the issue of excess nitrosamine impurities detected in some Januvia 50mg products, MSD Korea said, “The company has detected impurities that exceed the acceptable limit in two 50mg packaged batches among all Januvia products that were imported to Korea until October 2022. As a precautionary measure, the company has decided to voluntarily recall these products, and the level of impurity detected in the batches poses a negligible risk to patient safety."

According to MSD Korea, the company has been updating the Ministry of Food and Drug Safety on the company’s measures and plans for control since August last year when the company first became aware of possible detection of the ni